loader

cse:prev

LATEST ARTICLES
CSE:PREV
cannabis investing

PreveCeutical Reaches Milestone in Research Program for Development of Non-Addictive Analgesics

CSE:PREV
cannabis investing

PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property

CSE:PREV
cannabis investing

PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System

CSE:PREV
cannabis investing

PreveCeutical Announces Appointment of New Directors

CSE:PREV

PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program

CSE:PREV
cannabis investing

PreveCeutical Secures $300,000 Loan and Resignation of a Director

CSE:PREV

PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program

CSE:PREV
pharmaceutical investing

PreveCeutical Partnership Leads to Two New Patent Filings

CSE:PREV

PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program

CSE:PREV
cannabis investing

PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom in a Cell-Based Brain Cancer Model

CSE:PREV
cannabis investing

PreveCeutical Announces Default Judgment Against JCN Capital Corp.

CSE:PREV
cannabis investing

Retraction to News Release dated April 4, 2019

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES